Association of the CagA status of Helicobacter pylori and serum levels of interleukin (IL)-17 and IL-23 in duodenal ulcer patients

Journal of Digestive Diseases

Volumn 10, Issue 2, 2009, Pages 107-112

  Jafarzadeh, Abdollah ^a   Mirzaee, Vahid ^a   Ahmad Beygi, Hossain ^a   Nemati, Maryam ^a   Rezayati, Mohammad Taghi ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti CagA; Helicobacter pylori; Interleukin 17; Interleukin 23; Peptic ulcer

Indexed keywords

CAGA PROTEIN; INTERLEUKIN 17; INTERLEUKIN 23; PROTEIN ANTIBODY; VIRULENCE FACTOR;

ADULT; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEROLOGY;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DUODENAL ULCER; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; MIDDLE AGED;

EID: 65449174235     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2009.00371.x     Document Type: Article

References (35)

1. Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H. Helicobacter pylori endemic and gastric disease. Dig Dis Sci 2005; 50: 2075-80.
2. Bourke B. Will treatment of Helicobacter pylori infection in childhood alter the risk of developing gastric cancer? Can J Gastroenterol 2005; 19: 409-11.
3. Jafarzadeh A, Rezayati MT, Nemati M. Specific serum immunoglobulin G to H. pylori and CagA in healthy children and adults (south-east of Iran). World J Gastroenterol 2007; 13: 3117-21.
4. Figueiredo C, Marchado JC, Yamaoka Y. Pathogenesis of Helicobacter pylori infection. Helicobacter 2005; 10 (Suppl. 1): 14-20.
5. Umit H, Tezel A, Bukavaz S et al. The relationship between virulence factors of Helicobacter pylori and severity of gastritis in infected patients. Dig Dis Sci 2009; 54: 103-10.
6. Saadat I, Higashi H, Obuse C et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447: 330-3.
7. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by CagA gene positive Helicobacter pylori strains. Gut 1997; 41: 442-51.
8. Ando T, Perez-Perez GI, Kusugami K, Ohsuga M, Bloch KC, Blaser MJ. Anti-CagA immunoglobulin G responses correlate with interleukin-8 induction in human gastric mucosal biopsy culture. Clin Diagn Lab Immunol 2000; 7: 803-9.
9. + H. pylori infection is associated with polarization of T helper cell immune responses in gastric carcinogenesis. World J Gastroenterol 2007; 13: 2923-31.
10. Jimenze F, Demaria JL, Ahumada C et al. Seroprevalence of Helicobacter pylori anti-CagA antibodies and its relationship with epidemiologic factors in Santa Fe. Acta Gastroenterol Latinoam 2004; 34: 16-20.
11. Romagnani S. Human Th17 cells. Arthritis Res Ther 2008; 10: 206.
12. Gaffen SL. An overview of IL-17 function and signaling. Cytokine 2008; 43: 402-7.
13. Rutitzky LI, Lopes da Rosa JR, Stadecker MJ. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 2005; 175: 3920-6.
14. Zelante T, De Luca A, Bonifazi P et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37: 2695-706.
15. Kramer J, Gaffen S. Interleukin-17: A new paradigm in inflammation, autoimmunity and therapy. J Periodontol 2007; 78: 1083-93.
16. Caruso R, Pallone F, Monteleone G. Emerging role of IL-23/IL-17 axis in H. pylori-associated pathology. World J Gastroenterol 2007; 13: 5547-51.
17. Caruso R, Fina D, Paoluzi OA et al. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 2008 ; 38: 470-8.
18. Tesmer LA, Lundy SK, Sarkar S. Fox DA. Th17 cells in human disease. Immunol Rev 2008; 223: 87-113.
19. Garrett-Sinha LA, John S, Gaffen SL. IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 2008; 20: 519-25.
20. Maloy KJ. The Interleukin-23/interleukin-17 axis in intestinal inflammation. J Inter Med 2008; 263: 584-90.
21. Song C, Luo L, Lei Z et al. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 2008; 181: 6117-24.
22. Langrish CL, Chen Y, Blumenschein WM et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-40.
23. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24: 677-88.
24. Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25: 221-42.
25. Wu Q, Martin RJ, Rino JG, Breed R, Torres RM, Chu HW. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect 2007; 9: 78-86.
26. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004; 4: 467-76.
27. Hue S, Ahern P, Buonocore S et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006; 203: 2473-83.
28. Mitchell P, Germain C, Fiori PL et al. Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development. Infect Immun 2007; 75: 810-9.
29. D'Elios MM, Amedei A, Cappon A, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori (HPNAP) as an immune modulating agent. FEMS Immunol Med Microbiol 2007; 50: 157-64.
30. Amedei A, Cappon A, Codolo G et al. The neutrophil- activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 2006; 116: 1092-101.
31. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. IL-17 cytokine family. J Allergy Clin Immunol 2004 Dec; 114: 1265-73.
32. Nomura ANY, Pérez-Pérez GI, Lee J, Stemmermann G, Blaser MJ. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol 2002; 155: 1054-9.
33. Nilsson C, Sillén A, Eriksson L, Strand ML, Enroth H. Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease. Infection Immunity 2003; 71: 6573-81.
34. Jafarzadeh A, Salari M. Seroprevalence of anti- Helicobacter pylori and anti-CagA antibodies in peptic ulcer and healthy participants in the city of Rafsanjan. J Res Med Sci 2006; 11: 285-91.
35. Jafarzadeh A, Sajadi M. Evaluation of the serum Interleukin-18 levels in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor. Iran J Immunol 2006; 3: 15-22.